Aquestive's Anaphylm: Needle-Free Epinephrine on Track for FDA Approval
Anaphylm, Aquestive's needle-free sublingual epinephrine film for severe allergic reactions, is on track for FDA approval by Jan 31, 2026. It offers a device-free, orally delivered alternative to overcome needle fear.